NCT03751033已完成不适用
Influence of DisCoVisc OVD on Intraoperative Aberrometry Readings for Intraocular Lens (IOL) Calculations After Cataract Extraction
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 6
- 主要终点
- Differences in aphakic refractive measurements with BSS versus DiscoVisc
研究概览
简要总结
The purpose of the study is to develop a nomogram that correlates intraoperative, aphakic refraction measurements when the anterior chamber is pressurized with either balanced salt solution (BSS) or DisCoVisc; and to understand how suggested IOL power selection may differ.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 22 Years 至 95 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •In good general health
- •Between 22 and 95 years of age and diagnosed with cataract(s)
- •Able to comprehend and sign a written statement of informed consent for participation in the study, including HIPAA
- •Undergoing cataract extraction surgery with an Alcon SN6 platform intraocular lens implantation into the posterior chamber
- •Clear intraocular media, other than cataract
- •Potential postoperative best-corrected visual acuity (BSCVA) of 20/30 or better
- •Axial length of ≥ 22.00 and ≤ 28.00
排除标准
- •Concurrent participation in another investigational drug or device study or participation in another study within the last 30 days prior to Screening
- •Has had prior laser vision correction and/or corneal surgery
- •Has a complication during surgery unrelated to ORA use
- •Conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma or posterior capsule defects
- •History of infectious corneal disease (e.g., herpes simplex, herpes zoster, etc.) or other conditions which may result in corneal scarring
- •Significant central opacity/scar
- •Irregular astigmatism based upon investigator judgment
- •Inability to achieve keratometric stability
- •Will require another procedure, such as iris hooks, use of a Malyugin ring or insertion of a capsular tension ring during surgery
- •Will require significant sedation during surgery
- •Subject who is unable to maintain adequate fixation for image capture with ORA
- •Keratopathy/Kerectasia - any corneal abnormality, other than regular corneal astigmatism, including, but not limited to the following: corneal leukoma and pterygium
- •Any inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjunctivitis, and keratouveitis
- •May reasonably be expected to require a secondary surgical intervention at any time during the study (other than YAG capsulotomy)
- •Amblyopia
- •Corneal dystrophy (e.g., epithelial, stromal, or endothelial dystrophy)
- •Endothelial disease that may potentially affect visual outcome
- •Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal disorders) that are predicted (by subjective assessment of the retina) to cause future acuity losses to a level worse than 20/30 and/or that the investigator deems would interfere with acquiring images or determining a precise postoperative refraction
- •Shallow anterior chamber, not due to swollen cataract
- •History of retinal detachment or macular pucker
- •Ocular conditions such as keratoconus, forme fruste keratoconus or recurrent erosion syndrome that may predispose the subject to complications
- •Microphthalmos
- •Previous corneal transplant
- •Recurrent severe anterior or posterior segment inflammation of unknown etiology
- •Rubella or traumatic cataract
- •Iris neovascularization
- •Uncontrolled glaucoma or glaucoma with visual field defects
- •Poorly dilating pupil or other defect of the pupil that prevents the iris from adequate retraction peripherally
- •Ectopic pupil
- •Pupil abnormalities (nonreactive, fixed pupils; abnormally shaped pupils)
- •Prior, current, or anticipated use during the course of the study of tamsulosin or silodosin (e.g., Flomax, Flomaxtra, Rapaflo) likely, in the opinion of the Investigator, to cause poor dilation or lack of adequate iris structure to perform standard cataract surgery
- •Optic nerve atrophy
- •Uncontrolled systemic disease or acute or chronic disease or illness that would increase the operative risk or confound the outcome(s) of the study (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, multiple sclerosis, lupus, hepatitis, rheumatoid arthritis, etc.)
- •Uncontrolled/poorly controlled diabetes
- •Uncontrolled ocular hypertension (≥ 22 mmHg)
- •Active intraocular inflammation or recurrent ocular inflammatory \ condition (e.g., recurrent or persistent iritis, iridocyclitis, posterior uveitis, etc.)
- •Use of systemic or ocular medications that may affect vision
- •Recent ocular trauma that is not resolved/stable or may affect visual outcomes
- •Previous ocular surgery such as pterygium removal, tear duct surgery, radial keratectomy, etc.
- •Pregnant women, nursing women and subjects suspected of being pregnant
- •Subjects who, in the judgment of the investigator or sub-investigator, are inadequate for the study
结局指标
主要结局
Differences in aphakic refractive measurements with BSS versus DiscoVisc
时间窗: 1 Day
The differences in spherical equivalents will be evaluated using a nonparametric approach (Friedman chi-square test).
次要结局
- Difference between suggested IOL power selections with BSS versus DiscoVisc(1 Day)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
4 期
To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.CataractNCT00763360Alcon Research184
已完成
3 期
DisCoVisc Comparative EvaluationCataractsNCT00732225Alcon Research173
已完成
4 期
DisCoVisc Versus DuoVisc, Healon5 and AmVisc PlusCataractNCT00712244Alcon Research112
已完成
不适用
Advantage of Using Intraoperative Visual Evoked Potentials to Preserve Visual Function During Surgical Procedures Near the Optical PathwaysSurgeryOptic Nerve and Pathway InjuryNCT01517789University Hospital, Bordeaux40
招募中
不适用
Clinical Presentations and Surgical Outcome of Obstructive Müllerian AnomaliesMullerian Duct AnomaliesNCT06110052Assiut University36